Bavarian Nordic A/S (BAVA.CO) Financials
BAVA.CO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 14.4 billion | 4.0 billion |
2023-09-30 | 13.4 billion | 4.1 billion |
2023-06-30 | 15.0 billion | 5.3 billion |
2023-03-31 | 13.2 billion | 4.1 billion |
BAVA.CO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 341.3 million | 14.1 million |
2023-09-30 | 132.8 million | 9.8 million |
2023-06-30 | 125.2 million | 15.0 million |
2023-03-31 | -457.6 million | 16.6 million |
BAVA.CO Net Income
No data available :(
BAVA.CO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 128.3 million |
2023-09-30 | - | - | 88.6 million |
2023-06-30 | - | - | 103.7 million |
2023-03-31 | - | - | 68.2 million |
BAVA.CO Shares Outstanding
BAVA.CO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 244.1 million | 446.3 million | 255.6 million | - |
2023-09-30 | 30.3 million | 980.2 million | 207.9 million | - |
2023-06-30 | 152.4 million | 503.6 million | 253.1 million | - |
2023-03-31 | 152.4 million | 298.0 million | 155.9 million | - |
BAVA.CO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 2.4 billion | 832.8 million |
2023-09-30 | 1.4 billion | 514.4 million |
2023-06-30 | 2.0 billion | 683.7 million |
2023-03-31 | 1.3 billion | 428.4 million |
BAVA.CO
Price: DKK162.90
52 week price:
Earnings Per Share: 19.21 DKK
P/E Ratio: 16.15
Exchange: CPH
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 12.2 billion